Dianthus Therapeutics | MGTA - Market Capitalization


Dianthus Therapeutics reported $2.28B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 502M 75M Mar/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Deva Holding AS TRY 17.54B 7.76B Sep/2023
Dianthus Therapeutics USD 1.57B 967M Sep/2025
Divis Laboratories Ltd INR 1.7T 186.62B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Knight Therapeutics CAD 624.22M 38.25M Mar/2026
Laboratorios Farma EUR 4.16B 904.2M Mar/2026
Malin Corporation EUR 142.92M 19.65M Feb/2026
Medical Developments International AUD 38.41M 24.12M Mar/2026
Neuren Pharmaceuticals AUD 1.71B 645.78M Mar/2026
Organigram Holdings CAD 378.8M 132.2M Sep/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Ovoca Bio EUR 7.54M 4.28M Jun/2022
Pharma Mar EUR 1.41B 63.87M Mar/2026
Qiagen NV USD 9.9B 207.4M Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Sartorius EUR 16.41B 2.95B Dec/2025
Sino Biopharmaceutical CNY 114.44B 24.38B Mar/2026
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 14.34B 2.8B Dec/2025
Xeris Pharmaceuticals USD 1.32B 562M Sep/2025
Zealand Pharma A/S 33.35B 0 Feb/2026
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025